Summit Trail Advisors’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-18,497
Closed -$45K 423
2022
Q2
$45K Hold
18,497
﹤0.01% 377
2022
Q1
$128K Buy
+18,497
New +$196K 0.01% 313

Other funds holding RNLX

Summit Trail Advisors's RNLX Position: Q3 2022 in Review

Summit Trail Advisors sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2022, closing a stake of 18,497 shares — an estimated $45K sold.

Summit Trail Advisors first reported a position in RNLX in Q1 2022 and held it in 2 quarters. The position peaked at $128K in Q1 2022. 27 funds tracked by Wall St. Rank hold RNLX as of Q3 2022.

  • Summit Trail Advisors reported no remaining Renalytix plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Summit Trail Advisors sold 18,497 Renalytix plc American Depositary Shares shares in Q3 2022, an estimated $45K.
  • Summit Trail Advisors first reported a position in Renalytix plc American Depositary Shares in Q1 2022 and held it in 2 quarters.
  • Summit Trail Advisors's Renalytix plc American Depositary Shares position peaked at $128K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2022.

Based on Summit Trail Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.